Advertisement
Response to letter to the Editor| Volume 425, 117469, June 15, 2021

Reply to: Neurometabolic causes of dystonia: Sepiapterin reductase-deficient dopamine- and serotonin-responsive dystonia-plus syndrome

  • Chun Seng Phua
    Correspondence
    Corresponding author at: Department of Neurosciences, Alfred Hospital, 55 Commercial Road, Melbourne, VIC 3004, Australia.
    Affiliations
    Department of Neurosciences, Alfred Hospital, Melbourne, VIC, Australia

    Monash School of Medicine, Monash University, Melbourne, VIC, Australia
    Search for articles by this author
  • Kishore Raj Kumar
    Affiliations
    Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

    Molecular Medicine Laboratory, Concord Repatriation General Hospital, Sydney, NSW, Australia

    Neurology Department, Concord Repatriation General Hospital, Sydney, NSW, Australia

    Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
    Search for articles by this author
  • Stanley Levy
    Affiliations
    Department of Neurology, Campbelltown Hospital, NSW, Australia

    University of Western Sydney, School of Medicine, NSW, Australia
    Search for articles by this author
Published:April 20, 2021DOI:https://doi.org/10.1016/j.jns.2021.117469
Reply to: Neurometabolic causes of dystonia: Sepiapterin reductase-deficient dopamine- and serotonin-responsive dystonia-plus syndrome
Previous ArticleNeurometabolic causes of dystonia: Sepiapterin reductase-deficient dopamine- and serotonin-responsive dystonia-plus syndrome
Next ArticleReview of the neurological aspects of HIV infection
      Dear editor,

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Phua C.S.
        • Kumar K.R.
        • Levy S.
        Clinical characteristics and diagnostic clues to Neurometabolic causes of dystonia [Internet].
        J. Neurol. Sci.. Els. B.V. 2020; 419
        View in Article
        • Furukawa Y.
        • Kish S.
        Ardinger H.H. Adam M.P. Pagon R.A. Tyrosine Hydroxylase Deficiency. [Updated 2017 May 11]. GeneReviews® [Internet]. University of Washington, Seattle, Seattle (WA)2008 Feb 8 (Available from:)
        https://www.ncbi.nlm.nih.gov/books/NBK1437/
        View in Article
        • Willemsen M.A.
        • Verbeek M.M.
        • Kamsteeg E.J.
        • De Rijk-Van Andel J.F.
        • Aeby A.
        • Blau N.
        • et al.
        Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.
        Brain. 2010 Jun; 133: 1810-1822
        View in Article
        • Shalash A.S.
        • Rösler T.W.
        • Müller S.H.
        • Salama M.
        • Deuschl G.
        • Müller U.
        • et al.
        c.207C>G mutation in sepiapterin reductase causes autosomal dominant dopa-responsive dystonia.
        Neurol. Genet. 2017 Nov 1; 3: e197
        View in Article
        • Dill P.
        • Wagner M.
        • Somerville A.
        • Thöny B.
        • Blau N.
        • Weber P.
        Child neurology: paroxysmal stiffening, upward gaze, and hypotonia, Hallmarks of sepiapterin reductase deficiency.
        Neurology. 2012 Jan; 31: 78(5)
        View in Article
        • Antelmi E.
        • Stamelou M.
        • Liguori R.
        • Bhatia K.P.
        Nonmotor Symptoms in Dopa-Responsive Dystonia [Internet]. Vol. 2, Movement Disorders Clinical Practice.
        Wiley-Blackwell, 2015: 347-356
        View in Article
        • Marras C.
        • Lang A.
        • van de Warrenburg B.P.
        • Sue C.M.
        • Tabrizi S.J.
        • Bertram L.
        • et al.
        Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force [Internet].
        in: Movement Disorders. vol. 31. John Wiley and Sons Inc, 2016: 436-457
        View in Article
        • Timmers E.R.
        • Kuiper A.
        • Smit M.
        • Bartels A.L.
        • Kamphuis D.J.
        • Wolf N.I.
        • et al.
        Non-motor symptoms and quality of life in dopa-responsive dystonia patients.
        Parkinsonism Relat. Disord. 2017 Dec 1; 45: 57-62
        View in Article
        • Wijemanne S.
        • Jankovic J.
        Dopa-responsive dystonia - Clinical and genetic heterogeneity [Internet].
        in: Nature Reviews Neurology. vol. 11. Nature Publishing Group, 2015: 414-424
        View in Article
        • Furukawa Y.
        Adam M.P. Ardinger H.H. Pagon R.A. Wallace S.E. LJH Bean Stephens K. GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia. 2019 (editors. Seattle (WA))
        View in Article

      Article info

      Publication history

      Published online: April 20, 2021
      Accepted: April 19, 2021
      Received: April 18, 2021

      Identification

      DOI: https://doi.org/10.1016/j.jns.2021.117469

      Copyright

      © 2021 Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX